# Phase 3 colonic cancer trials recruiting: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials in phase 3 for colonic cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 colonic cancer trials: 25 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/colonic-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 16, 2026 | NCT07877597 | Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally... | Fudan University | Phase 3 | Not yet recruiting | Locally Advanced Colon Cancer, pMMR | 480 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877597) |
| June 25, 2026 | NCT07669519 | Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy | Sponsor not shown (see the record) | Phase 3 | Recruiting | Fatigue, Colon Cancer | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669519) |
| June 25, 2026 | NCT07669454 | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of... | Sponsor not shown (see the record) | Phase 3 | Recruiting | Fatigue Related to Cancer Treatment, Colon Cancer | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669454) |
| December 16, 2025 | NCT07284849 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line... | Incyte Corporation | Phase 3 | Recruiting | CRC (Colorectal Cancer) | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07284849) |
| October 30, 2025 | NCT07222800 | Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With... | Pfizer | Phase 3 | Recruiting | Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Neoplasms by Site, Digestive System... | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222800) |
| August 20, 2025 | NCT07132008 | Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer | First Affiliated Hospital of Guangxi Medical University | Phase 3 | Not yet recruiting | Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07132008) |
| May 30, 2025 | NCT06997497 | A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Colon Adenocarcinoma, Rectal Adenocarcinoma | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997497) |
| April 23, 2025 | NCT06940947 | Endoscopic Therapy Or Surgery for Early Colon Cancer | Norwegian Department of Health and Social Affairs | Phase 3 | Recruiting | Colon Cancer | 434 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06940947) |
| March 28, 2025 | NCT06899477 | Pre-Operative Treatment in REseCTable COlon CanceR | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Colo-rectal Cancer, Colon Cancer, Colon Carcinoma | 714 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06899477) |
| February 25, 2025 | NCT06845306 | The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage... | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Colo-rectal Cancer, Colonic Neoplasms Malignant | 1,268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06845306) |
| November 13, 2024 | NCT06686576 | A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer | Qilu Pharmaceutical Co., Ltd. | Phase 3 | Recruiting | Colon Cancer | 363 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06686576) |
| September 24, 2024 | NCT06609551 | ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized... | Zhejiang Cancer Hospital | Phase 3 | Recruiting | Colon Cancer, Colon Cancer (Stage II &Amp;Amp;Amp; III) | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06609551) |
| August 20, 2024 | NCT06563388 | Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial | Roswell Park Cancer Institute | Phase 3 | Recruiting | Oligometastasis, Lung Cancer, Colo-rectal Cancer, Prostate Cancer | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06563388) |
| July 8, 2024 | NCT06490536 | The Sagittarius Trial | IFOM ETS - The AIRC Institute of Molecular Oncology | Phase 3 | Recruiting | Colon Cancer Stage II, Colon Cancer Stage III | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06490536) |
| June 6, 2024 | NCT06446557 | De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent... | University Hospital, Rouen | Phase 3 | Not yet recruiting | Metastatic Colon Cancer | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06446557) |
| March 27, 2024 | NCT06332274 | tislelizUMaB in canceR Patients With molEcuLar residuaL Disease | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 | Recruiting | Cancer, Lung Cancer, Colo-rectal Cancer, Pancreas Cancer, Soft Tissue Sarcoma | 717 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06332274) |
| March 5, 2024 | NCT06293625 | Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More | Centre Hospitalier Universitaire Dijon | Phase 3 | Recruiting | Colon Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06293625) |
| January 17, 2024 | NCT06208371 | Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM | Sun Yat-sen University | Phase 3 | Recruiting | Colorectal Neoplasms Malignant | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06208371) |
| November 7, 2023 | NCT06119867 | CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE) | Russian Society of Colorectal Surgeons | Phase 3 | Recruiting | Colonic Neoplasms | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06119867) |
| October 30, 2023 | NCT06107920 | Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy | University Hospital, Rouen | Phase 3 | Recruiting | Colon Cancer | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06107920) |
| May 11, 2023 | NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | GlaxoSmithKline | Phase 3 | Recruiting | Colonic Neoplasms, Neoplasms, Colon | 892 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05855200) |
| February 2, 2023 | NCT05709249 | Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer | Jiangsu Famous Medical Technology Co., Ltd. | Phase 3 | Recruiting | Colon Cancer | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05709249) |
| September 9, 2022 | NCT05534087 | Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) | Seoul National University Hospital | Phase 3 | Recruiting | Colon Cancer | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05534087) |
| January 18, 2022 | NCT05194878 | Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers | Sun Yat-sen University | Phase 3 | Recruiting | Colon Cancer Stage II, Colon Cancer Stage III | 840 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05194878) |
| May 19, 2015 | NCT02448173 | A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer | Vaccinogen Inc | Phase 3 | Not yet recruiting | Stage II Colon Cancer | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02448173) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Sun Yat-sen University | 2 |
| University Hospital, Rouen | 2 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| [Jiangsu Famous Medical Technology Co., Ltd.](https://specstream.ai/data/clinical-trials/company/jiangsu-famous-medical-technology-co-ltd) | 1 |
| Vaccinogen Inc | 1 |
| Norwegian Department of Health and Social Affairs | 1 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 1 |
| Zhejiang Cancer Hospital | 1 |
| Russian Society of Colorectal Surgeons | 1 |
| Seoul National University Hospital | 1 |
| Roswell Park Cancer Institute | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| IFOM ETS - The AIRC Institute of Molecular Oncology | 1 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| Fudan University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 11 |
| France | 8 |
| Germany | 6 |
| United States | 6 |
| Italy | 5 |
| Poland | 5 |
| Spain | 5 |
| Argentina | 4 |
| Australia | 4 |
| Brazil | 4 |
| Canada | 4 |
| Japan | 4 |
| South Korea | 4 |
| Netherlands | 3 |
| Taiwan | 3 |
| United Kingdom | 3 |
| Belgium | 3 |
| India | 3 |
| Finland | 2 |
| Israel | 2 |
| Mexico | 2 |
| Turkey (Türkiye) | 2 |
| Denmark | 2 |
| Norway | 2 |
| Puerto Rico | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Infectious disease clinics in the United States](https://specstream.ai/data/businesses/infectious-disease-clinics/united-states)
- [Cleaning products suppliers in the United States](https://specstream.ai/data/businesses/cleaning-products-suppliers/united-states)
- [Truck and industrial vehicle companies in the United States](https://specstream.ai/data/businesses/truck-and-industrial-vehicle-companies/united-states)
- [Neuropathology practices in the United States](https://specstream.ai/data/businesses/neuropathology-practices/united-states)
- [European restaurants in the United States](https://specstream.ai/data/businesses/european-restaurants/united-states)
